558 related articles for article (PubMed ID: 18484339)
1. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
[TBL] [Abstract][Full Text] [Related]
2. AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment.
Gono T; Yazaki M; Fushimi T; Suzuki T; Uehara T; Sano K; Kametani F; Ito N; Matsushita M; Nakamura S; Hoshii Y; Matsuda M; Ikeda S
Am J Kidney Dis; 2006 May; 47(5):908-14. PubMed ID: 16632032
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
[TBL] [Abstract][Full Text] [Related]
5. Heavy-chain amyloidosis in TGFBI-negative and gelsolin-negative atypical lattice corneal dystrophy.
Pradhan MA; Henderson RA; Patel D; McGhee CN; Vincent AL
Cornea; 2011 Oct; 30(10):1163-6. PubMed ID: 21743312
[TBL] [Abstract][Full Text] [Related]
6. Renal AH Amyloidosis Associated With a Truncated Immunoglobulin Heavy Chain Undetectable by Immunostaining.
Manabe S; Hatano M; Yazaki M; Nitta K; Nagata M
Am J Kidney Dis; 2015 Dec; 66(6):1095-100. PubMed ID: 26362695
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
[TBL] [Abstract][Full Text] [Related]
8. ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review.
Wiegel NM; Mentele R; Kellermann J; Meyer L; Riess H; Linke RP
Amyloid; 2010 Mar; 17(1):10-23. PubMed ID: 20146644
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and origin of amyloid in kidney biopsies.
von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
[TBL] [Abstract][Full Text] [Related]
11. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
[TBL] [Abstract][Full Text] [Related]
12. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterisation of amyloid by endomyocardial biopsy.
Benson MD; Breall J; Cummings OW; Liepnieks JJ
Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
[TBL] [Abstract][Full Text] [Related]
14. Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.
Picken MM; Gallo G; Buxbaum J; Frangione B
Am J Pathol; 1986 Jul; 124(1):82-7. PubMed ID: 3089021
[TBL] [Abstract][Full Text] [Related]
15. Nephrotic syndrome and lambda light-chain monoclonal gammopathy suggestive of primary amyloidosis with positive staining for AA amyloid.
Riveiro-Barciela M; Martínez-Valle F; Vilardell-Tarrés M
J Am Geriatr Soc; 2012 Oct; 60(10):1974-5. PubMed ID: 23057449
[No Abstract] [Full Text] [Related]
16. Primary amyloidosis (AL) presenting with nephrotic syndrome: a case report and discussion.
Musolin L; Reyna R; DeBord J
W V Med J; 2003; 99(1):28-30. PubMed ID: 12762214
[TBL] [Abstract][Full Text] [Related]
17. A patient with severe renal amyloidosis associated with an immunoglobulin gamma-heavy chain fragment.
Yazaki M; Fushimi T; Tokuda T; Kametani F; Yamamoto K; Matsuda M; Shimojo H; Hoshii Y; Higuchi K; Ikeda S
Am J Kidney Dis; 2004 May; 43(5):e23-8. PubMed ID: 15112195
[TBL] [Abstract][Full Text] [Related]
18. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis).
Solomon A; Weiss DT; Murphy C
Am J Hematol; 1994 Feb; 45(2):171-6. PubMed ID: 8141123
[TBL] [Abstract][Full Text] [Related]
19. The pattern of amyloid deposition in the lung.
Looi LM
Malays J Pathol; 1999 Jun; 21(1):29-35. PubMed ID: 10879276
[TBL] [Abstract][Full Text] [Related]
20. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
